Effects of Active Anti-methamphetamine Vaccination on Intravenous Self-administration in Rats

Overview

Journal Drug Alcohol Depend

Publisher Elsevier

Specialty Psychiatry

Date 2015 Jun 30

PMID 26118833

Citations 24

Authors

M L Miller

S M Aarde

A Y Moreno

K M Creehan

K D Janda

M A Taffe

Affiliations

Soon will be listed here.

Abstract

Background: d-Methamphetamine (METH) addiction is a serious public health concern for which successful treatment remains elusive. Immunopharmacotherapy has been shown to attenuate locomotor and thermoregulatory effects of METH. The current study investigated whether active vaccination against METH could alter intravenous METH self-administration in rats.

Methods: Male Sprague-Dawley rats (Experiment 1: N=24; Experiment 2: N=18) were vaccinated with either a control keyhole-limpet hemocyanin conjugate vaccine (KLH) or a candidate anti-METH vaccine (MH6-KLH) or. Effects of vaccination on the acquisition of METH self-administration under two dose conditions (0.05, 0.1mg/kg/inf) and post-acquisition dose-substitution (0, 0.01, 0.05, 0.20mg/kg/inf, Experiment 1; 0.01, 0.05, 0.10, 0.15mg/kg/inf, Experiment 2) during steady-state responding were investigated. Plasma METH concentrations were determined 30min after an acute challenge dose of 3.2mg/kg METH.

Results: Active vaccination inhibited the acquisition of METH self-administration under the 0.1mg/kg/inf dose condition, with 66% of the MH6-KLH-vaccinated rats compared to 100% of the controls reaching criteria, and produced transient and dose-dependent effects on self-administration during the maintenance phase. Under the 0.05mg/kg/inf dose condition, MH6-KLH-vaccinated rats initially self-administered more METH than controls, but then self-administration decreased across the acquisition phase relative to controls; a subsequent dose-response assessment confirmed that MH6-KLH-vaccinated rats failed to acquire METH self-administration. Finally, plasma METH concentrations were higher in MH6-KLH-vaccinated rats compared to controls after an acute METH challenge, and these were positively correlated with antibody titers.

Conclusions: These data demonstrate that active immunopharmacotherapy for METH attenuates the acquisition of METH self-administration.

Citing Articles

Immunotherapeutic strategies for treating opioid use disorder and overdose.

Luba R, Martinez S, Jones J, Pravetoni M, Comer S Expert Opin Investig Drugs. 2023; 32(1):77-87.

PMID: 36696567 PMC: 10035039. DOI: 10.1080/13543784.2023.2173062.

Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines' immunogenicity.

Scendoni R, Bury E, Ribeiro I, Cameriere R, Cingolani M Hum Vaccin Immunother. 2022; 18(6):2140552.

PMID: 36351881 PMC: 9746524. DOI: 10.1080/21645515.2022.2140552.

A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects.

Celik M, Fuehrlein B Immunotargets Ther. 2022; 11:55-66.

PMID: 36199734 PMC: 9528911. DOI: 10.2147/ITT.S370435.

Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine.

Haile C, Varner K, Huijing X, Arora R, Orson F, Kosten T Vaccines (Basel). 2022; 10(9).

PMID: 36146588 PMC: 9503672. DOI: 10.3390/vaccines10091508.

The optimized jugular vein catheterization reinforced cocaine self-administration addictive model for adult male Sprague-Dawley rats.

Li Y, Qu L, Li N, Wang X, Wang P, Ge S Sci Rep. 2022; 12(1):11711.

PMID: 35810209 PMC: 9271077. DOI: 10.1038/s41598-022-15833-z.

References

Byrnes-Blake K, Carroll F, Abraham P, Owens S . Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats. Int Immunopharmacol. 2001; 1(2):329-38. DOI: 10.1016/s1567-5769(00)00019-9. View

Carrera M, Ashley J, Wirsching P, Koob G, Janda K . A second-generation vaccine protects against the psychoactive effects of cocaine. Proc Natl Acad Sci U S A. 2001; 98(4):1988-92. PMC: 29369. DOI: 10.1073/pnas.98.4.1988. View

Lindblom N, de Villiers S, Kalayanov G, Gordon S, Johansson A, Svensson T . Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration. 2002; 69(3):254-60. DOI: 10.1159/000063629. View

Cerny E, Levy R, Mauel J, Mpandi M, Mutter M, Henzelin-Nkubana C . Preclinical development of a vaccine 'against smoking'. Onkologie. 2002; 25(5):406-11. DOI: 10.1159/000067433. View

Carrera M, Ashley J, Hoffman T, Isomura S, Wirsching P, Koob G . Investigations using immunization to attenuate the psychoactive effects of nicotine. Bioorg Med Chem. 2004; 12(3):563-70. DOI: 10.1016/j.bmc.2003.11.029. View

Pickens R, Thompson T . Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed-ratio size. J Pharmacol Exp Ther. 1968; 161(1):122-9. View

Wilson M, Hitomi M, Schuster C . Psychomotor stimulant self administration as a function of dosage per injection in the rhesus monkey. Psychopharmacologia. 1971; 22(3):271-81. DOI: 10.1007/BF00401789. View

Wilson M, Schuster C . The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey. Psychopharmacologia. 1972; 26(2):115-26. DOI: 10.1007/BF00422098. View

Koob G, Le H, Creese I . The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Lett. 1987; 79(3):315-20. DOI: 10.1016/0304-3940(87)90451-4. View

10.

Caine S, Koob G . Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther. 1994; 270(1):209-18. View

11.

Carrera M, Ashley J, Parsons L, Wirsching P, Koob G, Janda K . Suppression of psychoactive effects of cocaine by active immunization. Nature. 1995; 378(6558):727-30. DOI: 10.1038/378727a0. View

12.

Aarde S, Huang P, Dickerson T, Taffe M . Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats. Psychopharmacology (Berl). 2014; 232(11):1867-77. PMC: 4426253. DOI: 10.1007/s00213-014-3819-4. View

13.

Aarde S, Miller M, Creehan K, Vandewater S, Taffe M . One day access to a running wheel reduces self-administration of D-methamphetamine, MDMA and methylone. Drug Alcohol Depend. 2015; 151:151-8. PMC: 4447594. DOI: 10.1016/j.drugalcdep.2015.03.016. View

14.

FOX B, Kantak K, Edwards M, Black K, Bollinger B, Botka A . Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med. 1996; 2(10):1129-32. DOI: 10.1038/nm1096-1129. View

15.

de Villiers S, Lindblom N, Kalayanov G, Gordon S, Johansson A, Svensson T . Active immunization against nicotine alters the distribution of nicotine but not the metabolism to cotinine in the rat. Naunyn Schmiedebergs Arch Pharmacol. 2004; 370(4):299-304. DOI: 10.1007/s00210-004-0960-3. View

16.

Keyler D, Roiko S, Benlhabib E, Lesage M, St Peter J, Stewart S . Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships. Drug Metab Dispos. 2005; 33(7):1056-61. DOI: 10.1124/dmd.105.004234. View

17.

Lesage M, Keyler D, Hieda Y, Collins G, Burroughs D, Le C . Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats. Psychopharmacology (Berl). 2005; 184(3-4):409-16. DOI: 10.1007/s00213-005-0027-2. View

18.

Lesage M, Keyler D, Pentel P . Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies. AAPS J. 2006; 8(1):E65-75. PMC: 3889506. DOI: 10.1208/aapsj080108. View

19.

Pitas G, Laurenzana E, Williams D, Owens S, Gentry W . Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted. Drug Metab Dispos. 2006; 34(6):906-12. DOI: 10.1124/dmd.105.005934. View

20.

Roll J, Petry N, Stitzer M, Brecht M, Peirce J, McCann M . Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry. 2006; 163(11):1993-9. DOI: 10.1176/ajp.2006.163.11.1993. View